WHY MOST CASE STUDIES FAIL UNDER EXECUTIVE SCRUTINY

By Peggy Ollison

Narrative Strategist & Case Study Architect for EHR and HealthTech Vendors

In healthcare technology, case studies are often treated as marketing assets: polished stories meant to inspire confidence. But when those same materials reach executive buyers, they frequently collapse under pressure.

Not because the outcomes aren't real. Not because the implementation wasn't successful. But because the proof isn't defensible.

Executives, clinicians, and operators aren't reading case studies for inspiration. They're evaluating risk. And most case studies aren't built to survive that shift in purpose.

Part of the reason is structural: case studies are typically created for marketing approval cycles, not executive review cycles. They're optimized for readability, brand voice, and broad appeal. Not for the questions a CFO or CMO will ask in a budget meeting.

That misalignment is baked in from the start.

The Moment Everything Breaks Down

A case study may read well on a website or in a sales deck, but the moment it enters an executive review, the questions sharpen:

•        How was this measured?

•        What changed operationally?

•        Is this transferable to our environment?

•        Would this hold up in an internal review?

If the narrative can't answer those questions cleanly, trust erodes. Quickly.

This is the point where momentum slows, skepticism rises, and what should be a strong proof point becomes a liability instead of an asset.

The Common Failure Points

Across vendor materials, the same patterns appear repeatedly:

1.      Metrics without context. Numbers are presented without baselines, definitions, or methodology. Executives don't trust metrics they can't interrogate.

2.       Improvements without operational detail. Claims of efficiency or time savings appear without explaining what actually changed in the workflow. Operators can't evaluate transferability without this.

3.       Testimonials that sound polished, not verifiable. Quotes are enthusiastic but vague. Clinical leaders want specificity, not sentiment.

4.       Outcomes that don't map to decision criteria. Vendors highlight what they think is impressive. Executives care about what reduces risk, cost, or friction.

5.       Stories that skip the before-state. Without a clear, unsustainable starting point, the impact feels abstract. Decision-makers need contrast to understand value.

These aren't cosmetic issues. They're credibility issues.

Why This Matters More in Healthcare

Healthcare technology purchases are high stakes. Every decision touches patient safety, clinical workflow, financial performance, regulatory exposure, and operational continuity.

Executives aren't looking for a good story. They're looking for proof they can defend when the decision is questioned.

A case study that can't withstand scrutiny doesn't just fail to persuade. It increases perceived risk.

The Real Problem: Case Studies Are Built for the Wrong Audience

Most case studies are created for marketing approval, not executive review. They're optimized for readability, brand voice, visual polish, and broad appeal.

But executives don't evaluate stories the way marketers do. They evaluate:

•        Defensibility

•        Methodology

•        Transferability

•        Operational credibility

•        Risk reduction

When a case study isn't built for that audience, it fails at the exact moment it's needed most.

What Strong Outcomes Actually Need

Strong implementations deserve strong proof.

Decision-grade evidence requires six elements working together: the kind that withstands scrutiny, earns trust, and moves enterprise-level decisions forward.

•        Clear baselines: what the starting point actually was, stated explicitly

•        Defined measurement methods: how improvement was tracked and by whom

•        Operational context: what changed in daily workflow, not just in aggregate metrics

•        Clinical relevance: how outcomes connect to patient care, not just operational efficiency

•        Quantifiable outcomes: specific numbers with time frames, not directional language

•        A believable human signal: real friction, real adaptation, real people. Not a frictionless success story.

When all six are present, a case study stops being a marketing asset and starts functioning as evidence.

The Bottom Line

You don't need more success stories.

You need case studies that can survive the moment of pressure: when questions sharpen, time compresses, and trust determines what moves forward.

Most case studies fail under executive scrutiny because they were never built for it.

NEXT IN THIS SERIES

The Anatomy of a Decision-Grade Case Study

A breakdown of the structural elements that make a case study defensible under scrutiny